Cat.#: ACPP-1249
Despition | TMPRSS2 Blocking Peptide for Immunocompeition, Immunodepletion |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1210 | Alpha SNAP Blocking Peptide (AC1210) | 250 µg | inquiry |
ACPP-1807 | Human QKI Protein (AC1807) | 2 µg | inquiry |
ACPP-1250 | Lin28 Blocking Peptide (AC1250) | 250 µg | inquiry |
ACPP-1469 | Human S100A8 Protein (AC1469) | 5 µg | inquiry |
ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
ACPP-1087 | Recombinant Human IL-6 Protein (Fc Chimera 6xHis Tag) (AC1087) | 50 µg | inquiry |
ACPP-1766 | Human HMGA2 Protein (AC1766) | 2 µg | inquiry |
ACPP-1369 | Parkin Blocking Peptide (AC1369) | 250 µg | inquiry |
ACPP-1271 | Alpha Synuclein Blocking Peptide (AC1271) | 250 µg | inquiry |
ACPP-1324 | Insulin Receptor Blocking Peptide (AC1324) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.